<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04988490</url>
  </required_header>
  <id_info>
    <org_study_id>21-3544.cc</org_study_id>
    <secondary_id>P30CA046934</secondary_id>
    <nct_id>NCT04988490</nct_id>
  </id_info>
  <brief_title>Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes</brief_title>
  <official_title>Quantification of Endo- and Phytocannabinoids With Comparison to Pain Medication Requirements and Surgical Outcomes for Patients Undergoing Abdominal Surgery for Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine how daily cannabis use affects surgical outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine if patients who are daily cannabis users that are undergoing inpatient abdominal&#xD;
      surgery for the treatment of cancer are different from non-cannabis users regarding&#xD;
      phytocannabinoid and endocannabinoid levels, pain scores, pain medication requirements, and&#xD;
      surgical complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 18, 2021</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">May 18, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>30 days</time_frame>
    <description>Postoperative opioid consumption among daily cannabis using and non-cannabis using patients undergoing abdominal surgery for cancer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of postoperative opioid consumption</measure>
    <time_frame>30 days</time_frame>
    <description>Correlation between serum phytocannabinoid and endocannabinoid levels, pain scores, and postoperative opioid consumption</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of postoperative complications</measure>
    <time_frame>30 days</time_frame>
    <description>Correlation between 30-day post-operative complications, preoperative, and postoperative phytocannabinoid and endocannabinoid levels</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Post-Surgical Pain</condition>
  <condition>Post-Surgical Complication</condition>
  <condition>Cancer</condition>
  <condition>Cannabis Use</condition>
  <arm_group>
    <arm_group_label>Daily cannabis users</arm_group_label>
    <description>Patients undergoing inpatient abdominal surgery for the treatment of cancer who self-report daily cannabis use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabis non-users</arm_group_label>
    <description>Patients undergoing inpatient abdominal surgery for the treatment of cancer who self-report no cannabis use</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cancer patients over the age of 21 undergoing inpatient abdominal surgery for the treatment&#xD;
        of cancer who use cannabis daily prior to surgery or who are non-users of cannabis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients &gt; 21 years old&#xD;
&#xD;
          -  Undergoing abdominal surgery for the treatment of cancer&#xD;
&#xD;
          -  Report no cannabis use in the last year or daily cannabis use&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with chronic pain, chronic pain syndrome on opioids&#xD;
&#xD;
          -  female patients who are pregnant or lactating&#xD;
&#xD;
          -  patients who report use of illicit substances&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Camille Sterwart</last_name>
    <role>Principal Investigator</role>
    <affiliation>Colorado Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Camille Stewart</last_name>
    <phone>2566941233</phone>
    <email>camille.stewart@cuanschutz.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nick Naughton</last_name>
    <phone>8327213237</phone>
    <email>nick.naughton@cuanschutz.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Colorado Research Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille Stewart</last_name>
      <phone>256-694-1233</phone>
      <email>camille.stewart@cuanschutz.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cannabis</keyword>
  <keyword>Post-Surgical Complications</keyword>
  <keyword>Post-Surgical Pain</keyword>
  <keyword>Abdominal Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

